Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.
Location: United States, New Jersey
Employees: 51-200
Investors 1
| Date | Name | Website |
| - | Perceptive... | perceptive... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 19.03.2024 | Aquestive Therapeutics Announces Pricing of $75 Million Unde... | - | globenewsw... |
| 05.03.2024 | Aquestive Therapeutics Reports Full Year 2023 Financial Resu... | - | globenewsw... |
| 02.11.2023 | Aquestive Therapeutics Completes $45 Million Debt Refinancin... | - | globenewsw... |
| 08.06.2022 | Aquestive Therapeutics, Inc. Announces Closing of $8.5 Milli... | WARREN, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharm... | globenewsw... |
| 06.06.2022 | Aquestive Therapeutics, Inc. Announces $8.5 Million Register... | WARREN, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharm... | globenewsw... |
| 25.11.2019 | Aquestive nabs FDA OK for oral film version of generic A... | The FDA has given Aquestive Therapeutics the green light to market Exservan, its oral film f... | endpts.com... |
| 28.06.2018 | Term Sheet — Thursday, June 28 | LYFTED Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From Extra... | fortune.co... |